EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Natural medicine‑empowered treatment of depression via restoring neurogenesis (Review)

Xiufen Zhong, Jingtao Gui

Molecular Medicine Reports · 2026

DOI: 10.3892/mmr.2026.14002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Xiufen Zhong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Psychogeriatric Ward, Chongqing Mental Health Center, Chongqing 401147, P.R. China. Hauptthemen laut MEDLINE: Neurogenesis, Antidepressive Agents, Biological Products, Major Depressive Disorder. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) remains a leading cause of disability, with a substantial proportion of patients failing to achieve adequate remission following conventional monoaminergic antidepressant treatment. The present narrative review examines evidence primarily published between 2015 and 2025 concerning natural medicines, including phytochemicals, traditional formulations, marine‑derived products and dietary polyphenols, that may modulate neurogenesis relevant to depression. Adult hippocampal neurogenesis is regarded as one mechanistic framework rather than the sole explanation for depressive pathology. Priority was given to clinical and human‑derived evidence, while preclinical studies are employed to elucidate underlying mechanisms. Natural products appear to converge on pathways involving brain‑derived neurotrophic factor/tropomyosin receptor kinase B, Wnt/β‑catenin, NF‑κB/NLR family pyrin domain containing 3‑mediated immune regulation, autophagy, mitochondrial bioenergetics and the gut microbiota. Nevertheless, current clinical evidence remains insufficient to support the use of natural medicines as substitutes for established antidepressant therapies. Their most plausible near‑term application lies in standardized adjunctive or investigational interventions, pending larger biomarker‑stratified trials, rigorous safety assessment and optimized formulation strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurogenesisAntidepressive AgentsBiological ProductsMajor Depressive DisorderDepressionHumansAnimalsHippocampus

Stichwörter der Autor:innen

brain‑derived neurotrophic factorhippocampusmajor depressive disordernatural medicinesneurogenesis

Substanzen

Antidepressive AgentsBiological Products

Autor:innen und Institutionen

  • Fifth Psychogeriatric Ward, Chongqing Mental Health Center, Chongqing 401147, P.R. China.

Zitieren

APA

Zhong, X., & Gui, J. (2026). Natural medicine‑empowered treatment of depression via restoring neurogenesis (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.14002

Vancouver

Zhong X, Gui J. Natural medicine‑empowered treatment of depression via restoring neurogenesis (Review). Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.14002

BibTeX
@article{Zhong2026,
  author = {Zhong, Xiufen and Gui, Jingtao},
  title = {Natural medicine‑empowered treatment of depression via restoring neurogenesis (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  doi = {10.3892/mmr.2026.14002}
}
Kostenlos starten →